Pricing delay raises shortage of medicine, counterfeiting risks
Federal cabinet yet to decide on proposals despite Drap recommending price revisions for 105 hardship-category medicines over two years ago.
Opening excerpt (first ~120 words) tap to expand
Pricing delay raises shortage of medicine, counterfeiting risks Imran Ayub Published July 13, 2026 Updated July 13, 2026 07:53am 0 Illustration photo shows various medicine pills in their original packaging in Brussels, Belgium, on August 9, 2019. — Reuters/File Listen to article 1x 1.2x 1.5x comments Join our Whatsapp Channel Add Dawn as a trusted source • Federal cabinet yet to decide on proposals despite Drap recommending price revisions for 105 hardship-category medicines over two years ago• Prolonged shortages creating opportunities for illegal suppliers to fill the gap, chemists’ body warns KARACHI: The prolonged shortage of more than 100 essential medicines, including life-saving drugs for cancer, heart disease and other serious illnesses, has created space for counterfeit and…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Dawn.